Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States

27Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

While evidence generated from health economic (HE) models is being used more commonly in health technology assessment (HTA) in the US, it is not consistently adopted by different stakeholder groups or across therapeutic areas. We hypothesize that actively engaging with multiple stakeholder groups throughout the model development process may result in models more widely considered by decision makers. To test this hypothesis, the Innovation and Value Initiative has launched a modeling effort to build an open-source HE model focusing on the disease state ‘major depressive disorder’. A 20-member advisory group has been formed with representatives from patients, employers, clinicians, innovators, payers, and researchers to guide the model development process. While this effort is still in the early stages, the ongoing stakeholder engagement effort has yielded valuable insights that inform the model design. We have also identified several challenges to implementing this new approach. Our early findings suggest that the stakeholder engagement approach to HE model development has the potential to improve HTA in the US.

Cite

CITATION STYLE

APA

Xie, R. Z., Malik, E. de F., Linthicum, M. T., & Bright, J. L. (2021). Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States. PharmacoEconomics, 39(6), 631–638. https://doi.org/10.1007/s40273-021-01036-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free